12:52 PM EST, 02/19/2025 (MT Newswires) -- AbbVie ( ABBV ) agreed to issue and sell a combined $4 billion in senior notes.

The sale includes $1.25 billion in 4.65% notes due 2028, $1 billion in 4.875% senior notes due 2030, $1 billion in 5.2% senior notes due 2035 and $750 million of 5.6% senior notes due 2055, AbbVie ( ABBV ) said Wednesday in a regulatory filing.

The 2028 notes will be priced at 99.867% of the principal amount with the 2030 notes at 99.908%, the 2035 notes at 99.857%, and the 2055 notes at 99.75%.

The company expects to close the sale on Feb. 26.

The net proceeds will be used to cover 2025 debt securities and general corporate purposes.

Price: 197.19, Change: +0.94, Percent Change: +0.48